Br J Haematol 2023 May 2
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Related Questions
New answer by at University of Nebraska Medical Center (January 1, 2024)
The short version of my answer is: Possibly Yes. There is a very limited evidence from the literature in this topic, however, I will base my explanation on the following ...